Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas R Webb

Showing results (41-50 of 78) with videos related to

Pageof 8
Sort By:
Journal of Medicinal Chemistry|November 3, 2009
Synthetic mRNA splicing modulator compounds with in vivo antitumor activityChandraiah Lagisetti, Alan Pourpak, Tinopiwa Goronga, et al.
Retrovirology|December 19, 2014
HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemiaMorgan Thénoz, Céline Vernin, Hussein Mortada, et al.
Pharmacology Research & Perspectives|July 15, 2015
Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidatesYihui Shi, Amanda S Joyner, William Shadrick, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonistsCharles Q Huang, Keith Wilcoxen, James R McCarthy, et al.
Journal of Combinatorial Chemistry|April 14, 2007
Application of a novel design paradigm to generate general nonpeptide combinatorial templates mimicking beta-turns: synthesis of ligands for melanocortin receptorsThomas R Webb, Luyong Jiang, Sergey Sviridov, et al.
Expert Review of Anticancer Therapy|March 12, 2009
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapyThomas R Webb, Jake Slavish, Rani E George, et al.
Plos One|May 30, 2020
An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applicationsYihui Shi, Walter Bray, Alexander J Smith, et al.
Scientific Reports|December 8, 2017
Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus EndonucleaseDiane Beylkin, Gyanendra Kumar, Wei Zhou, et al.
Plos Pathogens|August 10, 2012
Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonucleaseRebecca M DuBois, P Jake Slavish, Brandi M Baughman, et al.
Journal of Medicinal Chemistry|November 26, 2010
Structure-activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitorsBrandon M Young, Janice L Hyatt, David C Bouck, et al.
Pageof 8

Showing results (41-50 of 78) with videos related to

Sort By:
Pageof 8
Journal of Medicinal Chemistry|November 3, 2009
Synthetic mRNA splicing modulator compounds with in vivo antitumor activityChandraiah Lagisetti, Alan Pourpak, Tinopiwa Goronga, et al.
Retrovirology|December 19, 2014
HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemiaMorgan Thénoz, Céline Vernin, Hussein Mortada, et al.
Pharmacology Research & Perspectives|July 15, 2015
Pharmacodynamic assays to facilitate preclinical and clinical development of pre-mRNA splicing modulatory drug candidatesYihui Shi, Amanda S Joyner, William Shadrick, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2003
Synthesis and SAR of 8-arylquinolines as potent corticotropin-releasing factor1 (CRF1) receptor antagonistsCharles Q Huang, Keith Wilcoxen, James R McCarthy, et al.
Journal of Combinatorial Chemistry|April 14, 2007
Application of a novel design paradigm to generate general nonpeptide combinatorial templates mimicking beta-turns: synthesis of ligands for melanocortin receptorsThomas R Webb, Luyong Jiang, Sergey Sviridov, et al.
Expert Review of Anticancer Therapy|March 12, 2009
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapyThomas R Webb, Jake Slavish, Rani E George, et al.
Plos One|May 30, 2020
An exon skipping screen identifies antitumor drugs that are potent modulators of pre-mRNA splicing, suggesting new therapeutic applicationsYihui Shi, Walter Bray, Alexander J Smith, et al.
Scientific Reports|December 8, 2017
Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus EndonucleaseDiane Beylkin, Gyanendra Kumar, Wei Zhou, et al.
Plos Pathogens|August 10, 2012
Structural and biochemical basis for development of influenza virus inhibitors targeting the PA endonucleaseRebecca M DuBois, P Jake Slavish, Brandi M Baughman, et al.
Journal of Medicinal Chemistry|November 26, 2010
Structure-activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitorsBrandon M Young, Janice L Hyatt, David C Bouck, et al.
Pageof 8